Xcout IntelPMV Pharmaceuticals, Inc.
PMV Pharmaceuticals is a company developing first-in-class p53 regulators for the treatment of cancer by harnessing the power of the p53 protein.
Subscribe to see PMV Pharmaceuticals, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
PMV Pharmaceuticals, Inc. at a glance
PMV Pharmaceuticals, Inc. is a pharmaceuticals company headquartered in Princeton, United States, founded in 2013. It is publicly listed (PMVP) with a market capitalisation of $71.5M. Xcout tracks 29 named people at PMV Pharmaceuticals, Inc., including Robert Ticktin (General Counsel, Chief Operating Officer & Company Secretary).
PMV Pharmaceuticals, Inc. leadership
- Robert TicktinGeneral Counsel, Chief Operating Officer & Company Secretary
- Michael CarulliChief Financial Officer
- Deepika JalotaChief Development Officer
- Deepika Jalota, Pharm.D.Chief Development Officer
- Philip HermanChief Commercial Officer
- David H. MackCo-Founder, Chief Executive Officer, President & Director
23 more named people on record for PMV Pharmaceuticals, Inc., with roles, board committees and tenure — see the full roster →
PMV Pharmaceuticals, Inc. funding rounds on record
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series D | $70M | 7 named | |
| Series A | $30M | — |
Some filings are not shown as funding rounds.
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
PMV Pharmaceuticals, Inc. competitors
A few of PMV Pharmaceuticals, Inc.'s closest competitors — see the full list of competitors and alternatives →
Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.
Incyclix Bio is an oncology therapeutics company headquartered in Research Triangle Park, North Carolina. Founded by pioneers in CDK inhibitor discovery, research, and development, the company focuses on creating innovative cancer treatments.
Cao Pharmaceuticals Inc. develops anti-cancer drugs utilizing natural anti-cancer compounds. The company focuses on research, product pipelines, and developing lead drug candidates for cancer treatment.
Delta-Fly Pharma, Inc., established in Tokushima, Japan, in 2010, is a biotechnology company focused on the development of innovative oncology drugs. Their comprehensive pipeline includes several drug candidates targeting various cancers. DFP-10917 is currently undergoing Phase III clinical evaluation in the United States and Phase I in Japan for relapsed/refractory acute myeloid leukemia. Another significant compound, DFP-14323, is in Phase III trials for lung cancer. The firm is also advancing DFP-17729 through Phase I/II studies for solid tumors. Furthermore, DFP-11207 has successfully completed its Phase I clinical trial for pancreatic cancer. For hematologic malignancies, DFP-14927 is in Phase I, while DFP-10825 is in preclinical development, targeting gastric and ovarian cancers.
Kartos Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Redwood City, California. The company is dedicated to developing new therapies, including an investigational MDM2 inhibitor called navtemadlin.
Deciphera Pharmaceuticals, LLC is a commercial-stage biopharmaceutical company dedicated to delivering transformational medicines, such as QINLOCK, to patients for the treatment of cancer and rare diseases.
Get PMV Pharmaceuticals, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on PMV Pharmaceuticals, Inc. in Xcout Intel
- 29 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- 5 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access